Adaptive Biotechnologies Corporation provided revenue guidance for the first quarter ended March 31, 2024. For the period, total revenue of approximately $41 to $43 million for the first quarter of 2024, an increase of approximately 12% compared to the first quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | -2.79% | -11.87% | -28.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.78% | 529M | |
-27.66% | 9.41B | |
+26.94% | 2.9B | |
-15.73% | 2.16B | |
-20.83% | 1.7B | |
+67.18% | 1.51B | |
+26.08% | 814M | |
-4.15% | 760M | |
+3.98% | 312M | |
-24.19% | 183M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024